Old Mission Capital’s Greenwich LifeSciences GLSI Stock Holding History

Old Mission Capital’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,358	Closed	-$287K	–	1124
2021 Q3	$287K	Buy	+7,358	New	+$307K	0.01%	728

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Old Mission Capital's GLSI Position: Q4 2021 in Review

Old Mission Capital sold out of Greenwich LifeSciences (GLSI) in Q4 2021, closing a stake of 7,358 shares — an estimated $287K sold.

Old Mission Capital first reported a position in GLSI in Q3 2021 and held it in 1 quarter. The position peaked at $287K in Q3 2021. 35 funds tracked by Wall St. Rank hold GLSI as of Q4 2021.

Old Mission Capital reported no remaining Greenwich LifeSciences position as of Q4 2021 after selling out during the quarter.
Old Mission Capital sold 7,358 Greenwich LifeSciences shares in Q4 2021, an estimated $287K.
Old Mission Capital first reported a position in Greenwich LifeSciences in Q3 2021 and held it in 1 quarter.
Old Mission Capital's Greenwich LifeSciences position peaked at $287K in Q3 2021.
35 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2021.

Based on Old Mission Capital's 13F filing for Q4 2021, filed 10 Feb 2022.